Soon, the Food and Drug Administration (FDA) will decide whether or not to give an emergency use authorization to Johnson and Johnson for its one-dose coronavirus vaccine.
A report by the FDA says the vaccine is about 66 percent effective at preventing moderate to severe COVID-19.
On Friday, an advisory committee will meet to decide if the 66 percent is strong enough.† If the committee agrees that it is, the FDA will make a final decision soon thereafter.
Once approved, a few million doses are expected to be shipped within the first week.
This vaccine can be stored at normal refrigeration temperatures for three months.
The post One dose vaccine closer to approval appeared first on SuperTalk Mississippi.